{"id":"https://genegraph.clinicalgenome.org/r/83b58530-f612-41b3-9f92-dbcb12568004v1.0","type":"EvidenceStrengthAssertion","dc:description":"Dyskeratosis congenita (DC) is a multisystem disorder caused by defective telomere maintenance. Features are variable and include bone marrow failure, pulmonary and liver fibrosis, and premature graying of the hair (PMID: 16247010). TERT is one of the eleven genes encoding critical components of the telomere and telomerase complex that have been found to be mutated in individuals with DC. There is abundant evidence published associating the TERT gene with Dyskeratosis Congenita, since the gene-disease relationship was first proposed by Yamaguchi et al. (2005) (PMID: 15814878). Variants in TERT are considered to convey semi-dominant inheritance since both heterozygous and homozygous or compound heterozygous variants were reported in DC patients with different severity and age of onset. This is a lumped curation for Dyskeratosis congenita, autosomal dominant 2 (MIM: 613989), Dyskeratosis congenita, autosomal recessive 4 (MIM: 613989), Leukemia, acute myeloid (MIM: 601626) and Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1 (MIM: 614742). The MONDO entry of dyskeratosis congenita, autosomal dominant 2 is used in this curation, but a new disease entry is needed in the future for the telomere-mediated syndrome (PMID: 19405848). Multiple case level studies have been performed with DC patients that have variants in the TERT gene. A significant amount of case-level data is available, but the maximum points for genetic evidence has been reached (12 points). Multiple mouse models with TERT-specific deficiency or short telomeres have been established to show consistent phenotypes with DC patients, and TERT reactivation reverses tissue degeneration in aged mice. In summary, TERT is definitively associated with semi-dominant Dyskeratosis Congenita, the telomere-mediated syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/83b58530-f612-41b3-9f92-dbcb12568004","GCISnapshot":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-16T19:23:29.180Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-07-30T20:58:43.081Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/feb828da-680b-4119-abbd-cfaacaea90d6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"In vitro functional expression assays showed that the mutant protein had less than 50% residual activity.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf0cc29e-f90f-43fc-8de9-263129036632","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785587","rdfs:label":"Family AII-4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002745","obo:HP_0007427","obo:HP_0008404","obo:HP_0000957","obo:HP_0005528","obo:HP_0001873","obo:HP_0001915"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/feb828da-680b-4119-abbd-cfaacaea90d6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785587","allele":{"id":"https://genegraph.clinicalgenome.org/r/86ead6a9-8e90-459d-9504-65b2d19da031","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2431C>T (p.Arg811Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/29900"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ffca68e8-6bc2-4eb2-bd5f-65dec805f865_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Increase points because in vitro functional expression studies showed that the K902N mutant protein had almost no telomerase activity, resulting in haploinsufficiency.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6571a067-eacb-4029-a1b1-e999b466bda8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16247010","rdfs:label":"III1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001915","obo:HP_0002216","obo:HP_0002206","obo:HP_0000978","obo:HP_0002211","obo:HP_0012227","obo:HP_0000939","obo:HP_0001395"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ffca68e8-6bc2-4eb2-bd5f-65dec805f865_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16247010","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3daea5d-c86d-4fc2-8741-b8dec3d7d9b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2706G>C (p.Lys902Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12735"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/8af8be7f-4a54-4909-b21d-89405eb50ee3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Telomere length in patient granulocytes was less than 10% of control values, and cell lysates carrying the mutation showed less than 1% telomerase activity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01fcbdef-da32-4229-bdb2-65d9bcbfd9ba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","rdfs:label":"Patient E","ageType":"AgeAtReport","ageUnit":"Years","ageValue":34,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001915","obo:HP_0005528"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8af8be7f-4a54-4909-b21d-89405eb50ee3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","allele":{"id":"https://genegraph.clinicalgenome.org/r/dc0a7e9f-1448-452f-8109-259ca5e19077","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2080G>A (p.Val694Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12731"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bf2ece58-b207-4092-86b8-5cc063c4e1b2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Telomere length in patient granulocytes was less than 1% of control values, and cell lysates carrying the mutation showed less than 1% telomerase activity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea7ad97c-1038-4b29-9742-7c6e65d6e32c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","rdfs:label":"Patient F","ageType":"AgeAtReport","ageUnit":"Years","ageValue":53,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001915","obo:HP_0005528"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/bf2ece58-b207-4092-86b8-5cc063c4e1b2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce652d01-4aa6-4c34-99c3-06dd4467bfde","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2315A>G (p.Tyr772Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12732"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e8b5e63b-a468-41be-9fb1-33e0ed42285f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Telomere length in patient granulocytes was less than 10% of control values, and cell lysates carrying the mutation showed about 50% telomerase activity. 3 unrelated patients (Also PubMed: 18042801) with different race and ethnic backgrounds were reported but didn't give points because gnomAD AF is 0.003248 (646 variant alleles and 5 homozygous) and many labs classify this variant as Likely Benign/Benign in ClinVar.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/299cf9ac-9d97-466b-a13a-47210488aec7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","rdfs:label":"Patient C and D","ageType":"AgeAtReport","ageUnit":"Years","ageValue":56,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0005528","obo:HP_0001915"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e8b5e63b-a468-41be-9fb1-33e0ed42285f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9a4effb-8907-42dd-ac42-f7c03b6982ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.1234C>T (p.His412Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12730"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0f902c17-735e-421a-bd05-bca3b4bef2d0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The mutant protein had about 30% residual activity and affected individuals had shorter telomeres compared to family members without the mutation. Additionally, functional studies have demonstrated that R865H results in significantly reduced enzyme activities (PMID: 15885610) and therefore increase point to 1.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb993531-df99-4531-a74e-14b747d09299","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460043","rdfs:label":"F11 IV-1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":58,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0002206","obo:HP_0006530"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0f902c17-735e-421a-bd05-bca3b4bef2d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460043","allele":{"id":"https://genegraph.clinicalgenome.org/r/c905f0c8-b051-4156-9017-e3c744f3a536","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2594G>A (p.Arg865His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12736"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ed5f5df0-e2aa-452c-86b0-873e4f5e7d73_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Telomere length in patient granulocytes was less than 1% of control values, and cell lysates carrying the mutation showed less than 1% telomerase activity. This variant has been observed in an individual affected with aplastic anaemia, and an unrelated individual affected with hepatocellular carcinoma, but was also observed in one healthy individual (PMID: 15814878, 28813500, 19561322). Experimental studies using a cell model have shown that this variant results in a reduction of telomerase activity (PMID: 15814878, 23901009, 19561322, 26365799, 28813500, 28154186). But gnomAD AF 0.00004993 (14 variant alleles).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b07f78c-d399-412c-9978-01fac3a39934","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","rdfs:label":"Patient G","ageType":"AgeAtReport","ageUnit":"Years","ageValue":64,"detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0005528","obo:HP_0001915"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed5f5df0-e2aa-452c-86b0-873e4f5e7d73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","allele":{"id":"https://genegraph.clinicalgenome.org/r/545b5583-f8bc-46b8-b7a4-061adb887a7f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.3268G>A (p.Val1090Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12733"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9a3fd820-e51e-4310-9d79-47b24933bd60_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Telomere length in patient granulocytes was less than 10% of control values, and cell lysates carrying the mutation showed less than 1% telomerase activity. 2 unrelated patients were reported, but didn't increase points because another in vitro functional study demonstrated that a vector containing the A202T variant had activity and processing levels almost comparable to wild type (80-90%) (PMID: 15885610) and gnomAD AF is 0.0002996 (72 variant alleles).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2acacb32-60d3-46aa-a598-c4e455100a58","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","rdfs:label":"Patient A and B","ageType":"AgeAtReport","ageUnit":"Years","ageValue":41,"detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0005528","obo:HP_0001915"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9a3fd820-e51e-4310-9d79-47b24933bd60_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15814878","allele":{"id":"https://genegraph.clinicalgenome.org/r/e6f3ba8c-1d46-43fd-b415-5f0bf78d5c83","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.604G>A (p.Ala202Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12729"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2664e92-4645-4979-affc-83af85e8a85a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Heterozygosity for a +1G-A transition in intron 1 of the TERT gene, predicted to alter splicing. Telomere length in the lymphocytes was less than 1% of controls.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74b03d6c-c99f-4009-b353-56c8a2b083e8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17392301","rdfs:label":"BIII.5","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":58,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0006530","obo:HP_0002206"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d2664e92-4645-4979-affc-83af85e8a85a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17392301","allele":{"id":"https://genegraph.clinicalgenome.org/r/0ece776e-bbba-488b-9ddd-96b346fad9f7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.219+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12738"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/275e62d1-aaa7-4657-933d-5302653a60eb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Heterozygous 1-bp deletion (2240delT) in the TERT gene, creating a frameshift predicted to result in a truncated protein missing half of the reverse-transcriptase domain and the entire C terminus (Val747fsTer766). The mutant protein had essentially no enzymatic activity.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4ff72c3-b1af-4eb5-92fd-1bc6b57ff1cc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460043","rdfs:label":"F31 III-4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":67,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Linkage analysis","phenotypes":["obo:HP_0002206","obo:HP_0006530"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/275e62d1-aaa7-4657-933d-5302653a60eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460043","allele":{"id":"https://genegraph.clinicalgenome.org/r/82fd1a01-0ee4-485e-aba4-0625596f646c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2240delT (p.Val747Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12737"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/be758af3-4bf7-4219-ba83-d44902985e16_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Heterozygous A-to-C transversion at canonical splicing site of intron 9 of the TERT gene (IVS9-2A-C). Telomere length in lymphocytes was less than 10% of control values.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc77ee9b-5472-4c67-a8b3-d64b7648cafb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17392301","rdfs:label":"DIII.2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":48,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0006530","obo:HP_0002094","obo:HP_0002206"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/be758af3-4bf7-4219-ba83-d44902985e16_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17392301","allele":{"id":"https://genegraph.clinicalgenome.org/r/2307866a-360c-493c-bf57-82e10ef1da0b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2583-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/36944"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":4.5},{"id":"https://genegraph.clinicalgenome.org/r/7a658fa4-ffd7-4c3a-8132-b2db6f8181b8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"In vitro functional expression assays showed that the mutant protein had less than 25% residual activity.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11ddfc80-7088-4968-8751-f1b94e13b74c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785587","rdfs:label":"Family 2-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000252","obo:HP_0005528","obo:HP_0002015","obo:HP_0002745","obo:HP_0001873","obo:HP_0001321"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7a658fa4-ffd7-4c3a-8132-b2db6f8181b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785587","allele":{"id":"https://genegraph.clinicalgenome.org/r/883ac20d-b799-4572-8d22-d2dbb85a56e7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198253.2(TERT):c.2701C>T (p.Arg901Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/29901"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}},"zygosity":{"id":"cg:BiallelicHomozygous"}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d0e7321-0893-40dc-a738-5cdcc5dfb978_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460043","rdfs:label":"Family F31","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/4d0e7321-0893-40dc-a738-5cdcc5dfb978","type":"Family","rdfs:label":"Family F31","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/f4ff72c3-b1af-4eb5-92fd-1bc6b57ff1cc"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":7,"phenotypes":["obo:HP_0006530","obo:HP_0002206"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/f4ff72c3-b1af-4eb5-92fd-1bc6b57ff1cc"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/29777ea1-b692-4f13-847c-40c2019da3d9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785587","rdfs:label":"Family B","estimatedLodScore":0.37,"family":{"id":"https://genegraph.clinicalgenome.org/r/29777ea1-b692-4f13-847c-40c2019da3d9","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/11ddfc80-7088-4968-8751-f1b94e13b74c"},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000252","obo:HP_0001873","obo:HP_0002015","obo:HP_0005528","obo:HP_0002745","obo:HP_0001321"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/11ddfc80-7088-4968-8751-f1b94e13b74c"}},{"id":"https://genegraph.clinicalgenome.org/r/e2b39789-3a43-4a24-95a9-7fa79bac9172_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16247010","rdfs:label":"a three-generation AD DC kindred","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/e2b39789-3a43-4a24-95a9-7fa79bac9172","type":"Family","rdfs:label":"a three-generation AD DC kindred","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6571a067-eacb-4029-a1b1-e999b466bda8"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0001915","obo:HP_0000939","obo:HP_0012227","obo:HP_0002206","obo:HP_0000978","obo:HP_0001395","obo:HP_0002216","obo:HP_0002211"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6571a067-eacb-4029-a1b1-e999b466bda8"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ab92388c-e15d-4243-ade7-34604c4acd0f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17392301","rdfs:label":"Family D","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ab92388c-e15d-4243-ade7-34604c4acd0f","type":"Family","rdfs:label":"Family D","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/fc77ee9b-5472-4c67-a8b3-d64b7648cafb"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0006530","obo:HP_0002206","obo:HP_0002094"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/fc77ee9b-5472-4c67-a8b3-d64b7648cafb"}},{"id":"https://genegraph.clinicalgenome.org/r/386aa6a3-9116-4683-88c1-0f193c1e563a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17785587","rdfs:label":"Family A","estimatedLodScore":0.62,"family":{"id":"https://genegraph.clinicalgenome.org/r/386aa6a3-9116-4683-88c1-0f193c1e563a","type":"Family","rdfs:label":"Family A","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/cf0cc29e-f90f-43fc-8de9-263129036632"},"cg:modeOfInheritance":"Autosomal recessive"},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":5,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0005528","obo:HP_0002745","obo:HP_0008404","obo:HP_0000957","obo:HP_0001915","obo:HP_0007427","obo:HP_0001873"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cf0cc29e-f90f-43fc-8de9-263129036632"}},{"id":"https://genegraph.clinicalgenome.org/r/391dbfa6-3cbe-4236-9fb1-0d3c5c33484f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17392301","rdfs:label":"Family B","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/391dbfa6-3cbe-4236-9fb1-0d3c5c33484f","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/74b03d6c-c99f-4009-b353-56c8a2b083e8"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0006530","obo:HP_0002206"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/74b03d6c-c99f-4009-b353-56c8a2b083e8"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/7e645f81-6413-472d-8416-608f974275a1_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17460043","rdfs:label":"Family F11","estimatedLodScore":2.71,"family":{"id":"https://genegraph.clinicalgenome.org/r/7e645f81-6413-472d-8416-608f974275a1","type":"Family","rdfs:label":"Family F11","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/cb993531-df99-4531-a74e-14b747d09299"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":9,"phenotypes":["obo:HP_0002206","obo:HP_0006530"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cb993531-df99-4531-a74e-14b747d09299"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7494e439-365b-4517-acf3-e70b613b6a80","type":"EvidenceLine","dc:description":"Decrease points because the mice with short telomeres were not generated from TERT deficiency.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e26c884-75ec-4fac-920e-5848fc80e5e1","type":"Finding","dc:description":"Wildtype mice with short telomeres displayed hematopoietic and immune defects that resembled those present in patients with dyskeratosis congenita. Patients with dyskeratosis congenita have a premature aging syndrome that can be caused by mutations in the telomerase. When mice with short telomeres were interbred, telomere length was only incrementally restored, and even several generations later, wildtype mice with short telomeres still displayed degenerative defects. Histopathology identifies mucosal defects and bone marrow failure as the cause of death in mice with short telomeres.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19944403","rdfs:label":"Short Telomeres cause the degenerative defects of aging","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1600633e-1a79-4202-8891-333690f055cc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ccdec748-db60-4eac-afde-8915e640846d","type":"Finding","dc:description":"TERT-specific deficiency in mesenchymal cells caused attenuation of pulmonary fibrosis as manifested by reduced lung hydroxyproline content, type I collagen and Î±-smooth muscle actin mRNA levels. The TERT-deficient mouse lung fibroblasts displayed decreased cell proliferative capacity and higher susceptibility to induced apoptosis compared with control cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26555817","rdfs:label":"CKO TERT Mesenchymal Cells Impairs Mouse Pulmonary Fibrosis.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b8a53e8e-c373-4cd4-a0d4-0c55c88c9824","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4a67338-e7ba-4390-adef-c46530950265","type":"Finding","dc:description":"Homozygous TERT-ER mice had short dysfunctional telomeres and sustained increased DNA damage signaling and classical degenerative phenotypes upon successive generational matings and advancing age. Telomerase reactivation in such late generation TERT-ER mice extended telomeres, reduced DNA damage signaling and associated cellular checkpoint responses, allowed resumption of proliferation in quiescent cultures, and eliminated degenerative phenotypes across multiple organs including testes, spleen, and intestine.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21113150","rdfs:label":"TERT reactivation reverses tissue degeneration in aged mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/afb6ea76-e8ac-4a38-b42c-23fc18a9623b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a10e26c-0738-4339-8885-12f696eec08b","type":"EvidenceLine","dc:description":"Eleven different genes (DKC1, TERC, TERT, TINF2, NOP10, NHP2, WRAP53, ACD, RTEL1, PARN, CTC1) encoding critical components of the telomere have been found to be mutated in individuals with DC.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4ca261b-7ae8-4e0b-8891-20955ed73fff","type":"Finding","dc:description":"Telomerase (TERT) is a reverse transcriptase that uses its RNA component, TERC, to add the TTAGGG nucleotide repeats to the chromosome ends. WRAP53 (TCAB1) is required for the transport of telomerase to Cajal bodies for assembly of the holoenzyme complex. TINF2 encodes the TIN2 protein, which is a part of the shelterin telomere protection complex. The proteins encoded by DKC1, NHP2, and NOP10 are members of the H/ACA snoRNPs (small nucleolar ribonucleoproteins) gene family, which is involved in various aspects of rRNA processing and modification. These H/ACA snoRNP proteins are also components of the telomerase complex.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18054794","rdfs:label":"Dyskeratosis congenita is a disorder of telomere biology","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":1055,"specifiedBy":"GeneValidityCriteria7","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/oVpIomoA1Fg","type":"GeneValidityProposition","disease":"obo:MONDO_0013521","gene":"hgnc:11730","modeOfInheritance":"obo:HP_0032113"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_afb6ea76-e8ac-4a38-b42c-23fc18a9623b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}